Latest Breaking News On - Susanm manzi - Page 1 : comparemela.com
Lupus Foundation of America Unites Nationwide Lupus Community to Make an Impact for Lupus Awareness Month this May
Throughout May, the Foundation will lead the effort to raise lupus awareness and make lupus visible
News provided by
Share this article
Share this article
WASHINGTON, April 30, 2021 /PRNewswire/ This May for Lupus Awareness Month, the Lupus Foundation of America will continue its effort to
Make Lupus Visible, encouraging lupus warriors, family members and friends to raise awareness for the often invisible and devastating disease while also raising funds to support lupus research, education programs and support services.
Over half of Americans (63%) have never heard of or know little or nothing about lupus, underscoring the urgent need to raise awareness of the disease s brutal impact on every part of a person s life. Because many symptoms and effects of lupus are invisible, it can often leave those living with lupus feeling misunderstood and isolated.
United-states
Washington
Americans
America
Susanm-manzi
Stevanw-gibson
Maggie-maloney
Facebook
Lupus-foundation-of-america
Aurinia-pharmaceuticals
Allegheny-health-network-medicine-institute
Lupus-foundation-of-america-board
Lupus Foundation of America Congratulates Aurinia Pharmaceuticals on FDA Approval of Lupkynis™ (voclosporin) to Treat Lupus Nephritis
First FDA-approved oral treatment for lupus nephritis represents a significant milestone for people living with lupus-related kidney disease, a leading cause of disability and mortality in lupus
News provided by
Share this article
Share this article
WASHINGTON, Jan. 22, 2021 /PRNewswire/ For the second time in less than two months, the U.S. Food and Drug Administration (FDA) has approved a new medication to treat adults with lupus nephritis (lupus-related kidney disease) in combination with a background immunosuppressive therapy regimen. Today, Aurinia Pharmaceuticals announced they received authorization from the FDA to market Lupkynis™ (voclosporin), a first-ever oral therapy for lupus nephritis that blocks a protein in the immune system called calcineurin. The company previously had reported positive data from a late-stage clinical stu
Boston
Massachusetts
United-states
Washington
America
Susanm-manzi
Monique-gore-massy
Karenh-costenbader
Stevanw-gibson
Mike-donnelly
Lupus-foundation-of-america-ambassador
Drug-administration